Laboratory Monitoring for Patients on Apixaban

Standard Laboratory Tests

The American College of Cardiology suggests that anti-Factor Xa activity is the preferred test for measuring apixaban plasma levels, ideally calibrated specifically for apixaban 1
An anti-Xa activity of 0.35 U/mL corresponds to an apixaban level of approximately 30 μg/L 2

For suspected bleeding or emergency situations, the American College of Cardiology recommends that Prothrombin Time (PT) and International Normalized Ratio (INR) may be used for qualitative assessment but have limitations 3
Activated Partial Thromboplastin Time (aPTT) has limited sensitivity for apixaban and is not recommended for routine monitoring, as per the American College of Cardiology 3

For patients with fluctuating renal function, more frequent assessment of renal function may be appropriate, according to the Anaesthesia journal 4
Before invasive procedures, the Anaesthesia journal suggests that timing of last dose is more important than laboratory testing for most patients 4

The American College of Cardiology states that standard coagulation tests (PT, aPTT) have limited utility in assessing the anticoagulant effect of apixaban and may appear normal despite therapeutic anticoagulation 3
For life-threatening bleeding, measurement of anti-Xa activity can guide reversal strategies, though treatment should not be delayed while awaiting results, as recommended by Critical Care 1
For high hemorrhagic risk procedures, apixaban should typically be discontinued 3 days before the procedure when creatinine clearance is >30 mL/min, according to the Anaesthesia journal 4